Skip to content

Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function (ANOSPIN)

Anorectal Dysfunction in Patients Suffering From Spina Bifida : From Clinic to Neuro-epithelial Function

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02440984
Acronym
ANOSPIN
Enrollment
36
Registered
2015-05-12
Start date
2015-06-15
Completion date
2017-05-22
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spina Bifida

Keywords

enteric nervous system, anorectal disorder, barostat anorectal, physiology, spina bifida

Brief summary

The purpose of this study is to assess and explain (at least apart) anorectal disorders of patients with Spina Bifida by an automatic neuropathy responsive of enteric nervous system and epithelial barrier dysfunctions. The investigators' aim hypothetics is that autonomic neuropathy of patients with Spina Bifida induce enteric nervous sytem and epithelial barrier dysfunctions which explain anorectal disorders of these patients. Thexpect to show a decreased of 5% of enteric neurons per ganglia.

Detailed description

Spina Bifida is rare disease related to a failure of the closure of neural tube during the embryonic period. This malformation results in a variety of clinical disorders (neurologic, urologic, orthopedic, anorectal), depending on the level of the spinal cord lesion. Anorectal functional disorders remain underestimated and unknown from a pathophysiological point of view with subsequent uncodified therapeutic strategy. Patients with Spina Bifida always present autonomic neuropathy that contributes partially to the anorectal disorders. These disorders may be related to a closed relationship between autonomic and enteric nervous system. Both nervous systems play a key role in anorectal disorders during others neurological disaeses have a common and simultaneous development from neural crest and induce colonic epithelial changes related to the closed connection between epithelial barrier and enteric nervous system. All of this remains hypothetic because no data regarding the impairment of enteric nervous system and epithelial barrier are available and no study are ongoing on this topic.

Interventions

PROCEDUREColonic biopsies during endoscopy

eligible patients will have physical examination, colonic biopsies during endoscopy and anal manometry with barostat. these investigations are part of the usual healthcare. Colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system.

Sponsors

Rennes University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patient aged between 18 and 65 years old * patient who consulted to the national Spina Bifida Center for multidisciplinary assessment or for a proctology/urologic clinic * need of colonic biopsies during endoscopy * free, written and informed consent

Exclusion criteria

* pregnancy or breastfeeding * protected adults (judicial protection, guardianship and truesteeship) and persons deprived of liberty * patient unable to giving their consent * anticoagulants therapy or coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
number of enteric neurons per gangliadata collected at the day of endoscopyall data will be collected in the Spina Bifida database for further analyses. Colonic biopsies will be used to study intestinal permeability, colonic inflammation and enteric nervous system

Secondary

MeasureTime frameDescription
anorectal symptomsdata collected at the day of endoscopy
Rectal compliancedata collected at the day of endoscopyRectal compliance is defined by a volume variation during ascending pressure (phasic distension). It will be performed with a bag connected to electronic barostat.
Likert scaledata collected at the day of endoscopySensation intensity will be measured at each pressure step, by using 6-point Likert scale ranging from 0 (no sensation) to 6 (intolerable pain)
macroscopic and microscopic colonic inflammationdata collected at the day of endoscopy
intestinal permeability markerdata collected at the day of endoscopyIntestinal permeability will be measured using Ussing chamber.
number of glia cells per gangliadata collected at the day of endoscopy

Countries

France

Contacts

PRINCIPAL_INVESTIGATORCharlène Brochard, Md

Rennes University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026